glp-1 and bowel obstruction Receptor Agonists in Diabetes Obesity: A Case Report and Review of Risks and Management Weight Loss Drugs Like Ozempic,
Description
Factors that Influence Midlife Weight Gain An Aging Metabolism Everyone loses muscle as they age
2023;9(11) doi: 10.1016/j.heliyon.2023.e21233
A., & Tronieri, J
The FLOW trial with semaglutide showed significant reductions in kidney disease progression and cardiovascular death in patients with type 2 diabetes and chronic kidney disease
[Effect of exendin-4 on lipid deposition in skeletal muscle of diet-induced obese mice and its underlying mechanism]
